Oxaliplatin can exert good anti-tumor effects when combined with other drugs for chemotherapy when it meets the indications. Oxaliplatin is a kind of non-cycle-specific antitumor drug, this drug combined with 5-fluorouracil as well as folinic acid can be used as the first-line treatment for metastatic colorectal cancer, adjuvant treatment for stage III colon cancer after complete resection of the primary tumor, and also for locally advanced and metastatic hepatocellular carcinoma which is unsuitable for surgical resection or local treatment. In addition the drug can be combined with capecitabine and adjuvant chemotherapy for stage II or III gastric adenocarcinoma after radical resection. ADVERSE REACTIONS: Common adverse reactions that can be observed with oxaliplatin when combined with other drugs for chemotherapy include diarrhea, nausea, vomiting, thrombocytopenia, neutropenia, mucositis, and allergic reactions. CONTRAINDICATIONS: Oxaliplatin is contraindicated in nursing mothers and in persons with known hypersensitivity to oxaliplatin or other platinum compounds. Precautions: Oxaliplatin must be administered in a specialized oncology facility and under the supervision of an experienced oncologist. Allergic reactions occurring during administration should be discontinued immediately and treated accordingly. Oxaliplatin must be strictly under the guidance and supervision of a doctor, and once there is any abnormality after the use of the drug, the doctor must be informed immediately for treatment.